[Federal Register Volume 69, Number 217 (Wednesday, November 10, 2004)]
[Notices]
[Pages 65229-65230]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25102]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 16,

[[Page 65230]]

2004, Noramco Inc., 1440 Olympic Drive, Athens, Georgia 30601, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of Codeine (9050), a basic class of 
controlled substance in Schedule II.
    The company plans to utilize codeine to produce small quantities of 
naturally occurring codeine impurities for use in quality assurance and 
internal testing of the finished products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
January 10, 2005.

    Dated: November 1, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-25102 Filed 11-9-04; 8:45 am]
BILLING CODE 4410-09-P